Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018

Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2018’, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Bekhterev's Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Bekhterev's Disease)

- The report reviews pipeline therapeutics for Ankylosing Spondylitis (Bekhterev's Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved Ankylosing Spondylitis (Bekhterev's Disease) therapeutics and enlists all their major and minor projects

- The report assesses Ankylosing Spondylitis (Bekhterev's Disease) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news related to pipeline therapeutics for Ankylosing Spondylitis (Bekhterev's Disease)

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Ankylosing Spondylitis (Bekhterev's Disease)

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Ankylosing Spondylitis (Bekhterev's Disease) pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

AbbVie Inc

Adello Biologics LLC

Alteogen Inc

Amgen Inc

Biocad

Biocon Ltd

Bionovis SA

Celgene Corp

Coherus BioSciences Inc

Eli Lilly and Co

Fresenius SE ...

AbbVie Inc

Adello Biologics LLC

Alteogen Inc

Amgen Inc

Biocad

Biocon Ltd

Bionovis SA

Celgene Corp

Coherus BioSciences Inc

Eli Lilly and Co

Fresenius SE & Co KGaA

Galapagos NV

Genor BioPharma Co Ltd

Immunwork Inc

Innovent Biologics Inc

Izana Bioscience Ltd

Mycenax Biotech Inc

Nichi-Iko Pharmaceutical Co Ltd

Novartis AG

Nuevolution AB

Oncobiologics Inc

Pfizer Inc

Protalix BioTherapeutics Inc

Reliance Life Sciences Pvt Ltd

Sandoz International GmbH

Shanghai Pharmaceutical Co Ltd

Sun Pharma Advanced Research Company Ltd

UCB SA

Xbrane Biopharma AB

Table of Contents

Table of Contents

Table of Contents 2

Introduction 5

Ankylosing Spondylitis (Bekhterev's Disease) - Overview 6

Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Development 7

Ankylosing ...

Table of Contents

Table of Contents 2

Introduction 5

Ankylosing Spondylitis (Bekhterev's Disease) - Overview 6

Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Development 7

Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Assessment 14

Ankylosing Spondylitis (Bekhterev's Disease) - Companies Involved in Therapeutics Development 22

Ankylosing Spondylitis (Bekhterev's Disease) - Drug Profiles 36

Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects 182

Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products 184

Ankylosing Spondylitis (Bekhterev's Disease) - Product Development Milestones 185

Appendix 195

List of Tables

List of Tables

Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H1 2018

Number of Products under Development by Companies, H1 2018

Number ...

List of Tables

Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018

Products under Development by Companies, H1 2018

Products under Development by Companies, H1 2018 (Contd..1), H1 2018

Products under Development by Companies, H1 2018 (Contd..2), H1 2018

Number of Products by Stage and Target, H1 2018

Number of Products by Stage and Mechanism of Action, H1 2018

Number of Products by Stage and Route of Administration, H1 2018

Number of Products by Stage and Molecule Type, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by AbbVie Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Adello Biologics LLC, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Alteogen Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Amgen Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocad, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Biocon Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Bionovis SA, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Celgene Corp, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Coherus BioSciences Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Eli Lilly and Co, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Fresenius SE & Co KGaA, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Galapagos NV, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Genor BioPharma Co Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Immunwork Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Innovent Biologics Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Izana Bioscience Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Mycenax Biotech Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Nichi-Iko Pharmaceutical Co Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Novartis AG, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Nuevolution AB, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Oncobiologics Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Pfizer Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Protalix BioTherapeutics Inc, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Reliance Life Sciences Pvt Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Sandoz International GmbH, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Shanghai Pharmaceutical Co Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by UCB SA, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline by Xbrane Biopharma AB, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects, H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Projects, H1 2018 (Contd..1), H1 2018

Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products, H1 2018

List of Figures

List of Figures

Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H1 2018

Number of Products under Development by Companies, H1 2018

Number ...

List of Figures

Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), H1 2018

Number of Products under Development by Companies, H1 2018

Number of Products by Top 10 Targets, H1 2018

Number of Products by Stage and Top 10 Targets, H1 2018

Number of Products by Top 10 Mechanism of Actions, H1 2018

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018

Number of Products by Routes of Administration, H1 2018

Number of Products by Stage and Routes of Administration, H1 2018

Number of Products by Molecule Types, H1 2018

Number of Products by Stage and Top 10 Molecule Types, H1 2018

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports